NCT06817889: Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
- State
- Under way
- Phase
- Phase 2
- People
- 60 planned
- Started
- 23 Dec 2025
- Primary completion
- 30 Nov 2027
- Arms
- Treatment (remdesivir)
- Results
- None posted
- 10 Feb 2025: Trial registered
- 23 Dec 2025: Trial started